🇺🇸 FDA
Patent

US 9656999

Therapeutically active compounds and their methods of use

granted A61KA61K31/53A61K31/5377

Quick answer

US patent 9656999 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/53, A61K31/5377, A61P, A61P35/00